Document 0140
 DOCN  M9480140
 TI    [Current developments in antiviral chemotherapy. Part 4: Foscarnet,
       zidovudine, didanosine]
 DT    9410
 AU    Stamminger T; Fleckenstein B; Institut fur Klinische u. Molekulare
       Virologie der Univ.,; Erlangen.
 SO    Fortschr Med. 1994 May 10;112(13):190-1. Unique Identifier : AIDSLINE
       MED/94292065
 DE    AIDS-Related Opportunistic Infections/*DRUG THERAPY  Didanosine/ADVERSE
       EFFECTS/*THERAPEUTIC USE  Dose-Response Relationship, Drug  Drug
       Administration Schedule  Foscarnet/ADVERSE EFFECTS/*THERAPEUTIC USE
       Herpesviridae Infections/*DRUG THERAPY  Human  HIV Infections/*DRUG
       THERAPY  Zidovudine/ADVERSE EFFECTS/*THERAPEUTIC USE  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).